AU2006316813A1 - Formulation comprising a polyphenol-containing composition and isomaltulose - Google Patents
Formulation comprising a polyphenol-containing composition and isomaltulose Download PDFInfo
- Publication number
- AU2006316813A1 AU2006316813A1 AU2006316813A AU2006316813A AU2006316813A1 AU 2006316813 A1 AU2006316813 A1 AU 2006316813A1 AU 2006316813 A AU2006316813 A AU 2006316813A AU 2006316813 A AU2006316813 A AU 2006316813A AU 2006316813 A1 AU2006316813 A1 AU 2006316813A1
- Authority
- AU
- Australia
- Prior art keywords
- formulation
- weight
- polyphenol
- containing composition
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims description 242
- 238000009472 formulation Methods 0.000 title claims description 147
- 150000008442 polyphenolic compounds Chemical class 0.000 title claims description 96
- 235000013824 polyphenols Nutrition 0.000 title claims description 96
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 title claims description 72
- 239000000843 powder Substances 0.000 claims description 48
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 38
- 235000019640 taste Nutrition 0.000 claims description 37
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims description 26
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims description 26
- 229940030275 epigallocatechin gallate Drugs 0.000 claims description 25
- 239000000126 substance Substances 0.000 claims description 24
- 239000000284 extract Substances 0.000 claims description 20
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 19
- 229960001948 caffeine Drugs 0.000 claims description 19
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 19
- 235000003599 food sweetener Nutrition 0.000 claims description 16
- 239000003765 sweetening agent Substances 0.000 claims description 16
- 244000269722 Thea sinensis Species 0.000 claims description 15
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 claims description 13
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 claims description 13
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 claims description 12
- 241000124008 Mammalia Species 0.000 claims description 11
- 150000001720 carbohydrates Chemical class 0.000 claims description 11
- 235000013305 food Nutrition 0.000 claims description 11
- 230000000873 masking effect Effects 0.000 claims description 11
- 235000013615 non-nutritive sweetener Nutrition 0.000 claims description 9
- 235000006468 Thea sinensis Nutrition 0.000 claims description 7
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000019634 flavors Nutrition 0.000 claims description 7
- 235000019156 vitamin B Nutrition 0.000 claims description 7
- 239000011720 vitamin B Substances 0.000 claims description 7
- LSHVYAFMTMFKBA-PZJWPPBQSA-N (+)-catechin-3-O-gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-PZJWPPBQSA-N 0.000 claims description 6
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 claims description 6
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 claims description 6
- WMBWREPUVVBILR-NQIIRXRSSA-N (-)-gallocatechin gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-NQIIRXRSSA-N 0.000 claims description 6
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 150000007513 acids Chemical class 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 claims description 6
- 235000012734 epicatechin Nutrition 0.000 claims description 6
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 claims description 6
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 6
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 claims description 6
- 235000009569 green tea Nutrition 0.000 claims description 6
- 239000000419 plant extract Substances 0.000 claims description 6
- 230000004060 metabolic process Effects 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 150000001765 catechin Chemical class 0.000 claims description 4
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 4
- 235000005487 catechin Nutrition 0.000 claims description 4
- 239000000979 synthetic dye Substances 0.000 claims description 4
- XMOCLSLCDHWDHP-DOMZBBRYSA-N (-)-gallocatechin Chemical compound C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-DOMZBBRYSA-N 0.000 claims description 3
- 235000020279 black tea Nutrition 0.000 claims description 3
- 239000003623 enhancer Substances 0.000 claims description 3
- 235000004515 gallic acid Nutrition 0.000 claims description 3
- 229940074391 gallic acid Drugs 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 235000010755 mineral Nutrition 0.000 claims description 3
- 239000000978 natural dye Substances 0.000 claims description 3
- 235000020333 oolong tea Nutrition 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 239000011573 trace mineral Substances 0.000 claims description 3
- 235000013619 trace mineral Nutrition 0.000 claims description 3
- 240000000560 Citrus x paradisi Species 0.000 description 16
- 235000019658 bitter taste Nutrition 0.000 description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
- 229930006000 Sucrose Natural products 0.000 description 11
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 11
- 239000008103 glucose Substances 0.000 description 11
- 239000005720 sucrose Substances 0.000 description 11
- 229930091371 Fructose Natural products 0.000 description 10
- 239000005715 Fructose Substances 0.000 description 10
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 10
- 229960004543 anhydrous citric acid Drugs 0.000 description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 8
- 150000004683 dihydrates Chemical class 0.000 description 8
- 239000001509 sodium citrate Substances 0.000 description 8
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 8
- 229940038773 trisodium citrate Drugs 0.000 description 8
- 241000282412 Homo Species 0.000 description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 7
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 230000001953 sensory effect Effects 0.000 description 6
- 206010013911 Dysgeusia Diseases 0.000 description 5
- 239000004376 Sucralose Substances 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 229960004903 invert sugar Drugs 0.000 description 5
- 235000019408 sucralose Nutrition 0.000 description 5
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- 230000014616 translation Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 235000015523 tannic acid Nutrition 0.000 description 4
- 229920002258 tannic acid Polymers 0.000 description 4
- 235000013616 tea Nutrition 0.000 description 4
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000001263 FEMA 3042 Substances 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000000905 isomalt Substances 0.000 description 2
- 235000010439 isomalt Nutrition 0.000 description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 2
- 229940033123 tannic acid Drugs 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 239000006068 taste-masking agent Substances 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- KHUCJYKEMPZNQO-NLVJPSFISA-N (3s,4r,5r)-1,3,4,5,6-pentahydroxy-1-[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]hexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)C(O)C1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KHUCJYKEMPZNQO-NLVJPSFISA-N 0.000 description 1
- DXALOGXSFLZLLN-WTZPKTTFSA-N (3s,4s,5r)-1,3,4,6-tetrahydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-one Chemical compound OCC(=O)[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DXALOGXSFLZLLN-WTZPKTTFSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SERLAGPUMNYUCK-YJOKQAJESA-N 6-O-alpha-D-glucopyranosyl-D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-YJOKQAJESA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- GGLIEWRLXDLBBF-UHFFFAOYSA-N Dulcin Chemical compound CCOC1=CC=C(NC(N)=O)C=C1 GGLIEWRLXDLBBF-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- JPFGFRMPGVDDGE-UHFFFAOYSA-N Leucrose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)(CO)OC1 JPFGFRMPGVDDGE-UHFFFAOYSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229940043202 calcium cyclamate Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001766 catechin derivatives Chemical class 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- 239000008126 dulcin Substances 0.000 description 1
- NWNUTSZTAUGIGA-UHFFFAOYSA-N dulcin Natural products C12CC(C)(C)CCC2(C(=O)OC2C(C(O)C(O)C(COC3C(C(O)C(O)CO3)O)O2)O)C(O)CC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1OC1OC(CO)C(O)C(O)C1O NWNUTSZTAUGIGA-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- LFVPBERIVUNMGV-UHFFFAOYSA-N fasudil hydrochloride Chemical compound Cl.C=1C=CC2=CN=CC=C2C=1S(=O)(=O)N1CCCNCC1 LFVPBERIVUNMGV-UHFFFAOYSA-N 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 235000020344 instant tea Nutrition 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 150000003267 reducing disaccharides Chemical class 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 150000004961 triphenylmethanes Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940045999 vitamin b 12 Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 125000001834 xanthenyl group Chemical class C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/163—Liquid or semi-liquid tea extract preparations, e.g. gels, liquid extracts in solid capsules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/84—Flavour masking or reducing agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Seasonings (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Description
LAWYERS' AND MERCHANTS' TRANSLATION BUREAU, INC. Legal, Financial, Scientific, Technical and Patent Translations 11 BROADWAY NEW YORK, NY 10004 Certificate of Accuracy TRANSLATION From: German Into English STATE OF NEW YORK COUNTY OF NEW YORK s.s.: On this day personally appeared before me who, after being duly sworn, deposes and states: That I, Charles Sitch, Authorized Officer of LAWYERS' AND MERCHANTS' TRANSLATION BUREAU declare That to the best of my knowledge and belief, the attached document, prepared by one of Its translators competent in the art and conversant with the German and English languages, is a true and correct translation into the English language of the accompanying document. SUBSCRIBED AND SWORN TO BEFORE ME THIS MAY 14 2008 Susan Tapley Notary Public, State of New York No. 01TA4999804 Qualified In Queens County Certificates filed in New York County and Kings County Commission expires July 27, 2010 Gleiss & GroBe Intellectual Property and Technology Law PATENT APPLICATION Formulation containing a polyphenol-containing composition and isomaltulose SUDZUCKER Aktiengesellschaft Mannheim/Ochsenfurt MaxmilianstraBe 10 D-68165 MANNHEIM Germany and DSM IP Assets B.V. Het Overloon 1 NL-6411 TE Heerlen Netherlands {00930521.1) Formulation containing a polyphenol-containing composition and isomaltulose Description The present invention relates to formulations containing polyphenol-containing compositions and isomaltulose, uses of the above-mentioned formulation and also the use of isomaltulose as taste-masking agent in a formulation containing a polyphenol-containing composition. In a great multiplicity of foods and articles consumed for pleasure and also, in particular, in drinks, there are a number of bitter substances, some wanted, but some unwanted, that is to say compounds which give rise to a bitter taste for the consumers, in particular human consumers. Typical bitter substances are, for example, substances from the class of glycosides, but also isoprenoids and catechins which are the base substance of a multiplicity of oligomeric or polymeric tannins. Polyphenol-based bitter substances are also present in teas or tea extracts. Such extracts also include extracts of green tea, for example the extract, also named TEAVIGO@ from leaves of green tea which contains at least 90% epigallocatechin gallate (EGCG). Although this already has a relatively acceptable degree of bitterness, for some consumers it is still too bitter. Tannins such as tannic acids generally have a bitter taste {00930521.1} - 2 which can be a nuisance in drinks and goods, articles consumed for pleasure or medicaments. US patent 5,902,628 describes shortening a persistent sweet aftertaste of the intense sweetener sucralose by admixing tannic acids. Although the tannic acid according to this publication beneficially affects the strongly sweet aftertaste of sucralose which is considered a disadvantage, nevertheless the bitter taste of tannic acid in many applications proves to be disadvantageous, despite the simultaneous presence of sucralose. The reducing disaccharide ketose isomaltulose (6-0-a D-glucopyranosylfructose) which occurs naturally, for example in honey, and is also known to those skilled in the art as Palatinose@, is principally used as starting material for producing isomalt, a virtually equimolar mixture of the diastereomers 6-0-ca-D-glucopyranosyl-D-sorbitol (1,6-GPS) and 1-0-a-D-glucopyranosyl-D-mannitol (1,1-GPM). As sweetening agent, isomaltulose, owing to its low sweetening power and the taste resulting therefrom is principally used in combination with sugar replacers and/or sweeteners in foods. Owing to delayed breakdown of isomaltulose which takes place first in the region of the small intestine, isomaltulose is also used in special foods for athletes in order to maintain oxidative metabolism. Isomaltulose crystallizes in the form of a monohydrate. The solubility of isomaltulose in water is (00930521.1) -3 0.49 g of anhydrous isomaltulose per g of water. Isomaltulose has advantageous acariogenic properties, since it is scarcely broken down by the human oral flora. Isomaltulose is only cleaved with a delay by the glucosidases of the human small intestinal wall, wherein the resultant breakdown products glucose and fructose are resorbed. This results in a slow rise in blood glucose, compared with rapidly digestible carbohydrates. Isomaltulose, in contrast to rapidly digestible, high-glycemic foods, scarcely requires insulin for metabolism. Isomaltulose is also used in part to mask the unpleasant taste of other foods. EP 0 809 939 Al describes a yoghurt which contains lactic acid bacteria and bifido bacteria which also contains refined fish oil having a high fraction of unsaturated fatty acids, and also a sweetening agent, for example isomaltulose. The addition of isomaltulose is intended to prevent the development of the typical fish taste and fish odor. JP 63152950 A2 describes the production of vegetable jelly products, using vegetables and a gelling agent, wherein isomaltulose and other additives such as cinnamon are used in order to mask the unpleasant odor of vegetable components. DE 690 005 48 T2 describes sweetener compositions containing sucralose and isomaltulose, wherein these compositions have a synergistic effect, that is to say exhibit a greater sweetening power than would be expected by (00930521.1) -4 simple addition of the sweetening power exhibited by the sweetener components. The sweetener mixture can be used, for example, for producing drinks and confectionery products. However, there is still a requirement for a teaching according to which the unwanted bitter taste of bitter substances, in particular polyphenol-based bitter substances, in formulations, that is say, for example, foods, drinks, medicaments or articles consumed for pleasure, can be masked and thus as far as possible removed from perception by the consumer. Taste here is taken to mean the chemical sense of humans for perception and differentiation of foodstuffs. Humans can essentially differentiate four taste qualities: sweet, sour, bitter and salty. The taste stimulus occurs by activation of a taste sensory cell by the addition of molecules of a taste substance to receptor molecules. A taste stimulus can be expressed differently not only in its quality, for example whether it is sweet, sour, bitter, salty, or a mixture thereof, in its intensity, that is to say the taste strength, and also in its duration. The technical problem therefore underlying the present invention is to provide a teaching according to which the unwanted bitter taste of bitter substances, in particular polyphenol-containing compositions, is masked in a formulation, that is say is no longer perceived, or is perceived only to a greatly reduced extent, by the consumer, (00930521.1} -5 in particular human or animal consumer, in particular a bitter taste impression during and after consumption is no longer perceived. The present invention solves its underlying technical problem by providing the teaching of using isomaltulose in order to mask the bitter taste of polyphenol-containing mixtures, in particular compositions. The invention solves its underlying problem, in particular, also, by providing a formulation containing a polyphenol-containing composition and isomaltulose. The invention therefore relates to the teaching of using isomaltulose together with an, in particular bitter tasting, polyphenol-containing composition, wherein the isomaltulose masks the otherwise bitter taste of the polyphenol-containing composition. According to the invention the isomaltulose therefore acts as taste-masking agent, which acts not only during the consumption of the polyphenol-containing composition, or of a formulation which contains a polyphenol-containing composition, but also masks the bitter taste which is otherwise also perceived by the consumer after consumption, that is say the aftertaste. Advantageously, by this means a formulation can be provided which, owing to the isomaltulose used, has sweetening power, but is nonetheless protective to teeth, acariogenic, non laxative, and suitable for diabetics. In the context of the present invention, taste masking of a polyphenol-containing composition is taken to {00930521.1} -6 mean that a taste of the polyphenol-containing composition which is perceived as bitter by test persons of competence in the art in a comparison formulation with polyphenol containing composition and comparison sweetener is perceived in a statistically meaningful manner to a significantly reduced extent, preferably no longer at all, when this polyphenol-containing composition is present in a formulation of the invention together with isomaltulose instead of with the comparison sweetener. In the context of the present invention, a bitter tasting polyphenol-containing composition is taken to mean a composition which contains polyphenols, in particular polyphenol derivatives, in an amount which is considered as bitter tasting by test persons of competence in the art in a statistically meaningful manner. In a preferred embodiment, a polyphenol-containing composition of the present invention is a composition which has catechin derivatives, preferably at least 90% by weight, in particular at least 94% by weight, in each case based on the dry matter of the composition. In a particularly preferred embodiment, the polyphenol-containing composition of the present invention is a composition which contains at least 90% by weight epigallocatechin gallate, hereinafter also termed EGCG (polyphenol(-)-epigallocatechin 3-gallate), preferably at least 94% by weight EGCG (in each case based on dry matter of the polyphenol-containing composition). (00930521.1} In a particularly preferred embodiment of the present invention, this relates to a formulation which contains a polyphenol-containing composition and isomaltulose, wherein the polyphenol-containing composition has a fraction of at least 90% by weight, preferably at least 94% by weight, of EGCG, in each case based on the weight of the dry matter of the polyphenol-containing composition. In a further preferred embodiment, the invention relates to an above-mentioned formulation, wherein the polyphenol-containing composition has a fraction of at most 2.5% by weight of caffeine, preferably at most 0.1% by weight of caffeine, in each case based on the weight of the dry matter of the polyphenol-containing composition. In a further preferred embodiment, the present invention relates to an above-mentioned formulation, wherein the polyphenol-containing composition has a fraction of at most 2.5% by weight of gallocatechin gallate (GCG), based on the weight of the dry matter of the polyphenol-containing composition. The invention relates in a further preferred embodiment to a formulation of the above-mentioned type, wherein the polyphenol-containing composition has a fraction of at most 5.0% by weight of epicatechin gallate (ECG), preferably at most 3.0% by weight ECG, in each case based on the weight of the dry matter of the polyphenol-containing composition. (00930521.1) -8 The invention relates in a further preferred embodiment to an above-mentioned formulation wherein the polyphenol-containing composition has a fraction of at most 0.1% by weight of gallic acid, based on the weight of the dry matter of the polyphenol-containing composition. The invention further relates in a further preferred embodiment to a formulation of the above-mentioned type, wherein the polyphenol-containing composition, apart from EGCG, has a fraction of at most 5.0% by weight of other polyphenols and catechins such as gallocatechin gallate (GCG), catechin gallate (CG), epicatechin gallate (ECG), epigallocatechin (EGC), gallocatechin (GC) and epicatechin (EC), in each case based on the weight of the dry matter of the polyphenol-containing composition. In a preferred embodiment, the polyphenol-containing composition is TEAVIGO@. TEAVIGO@ is a highly purified extract of leaves of the green tea Camellia sinensis and has at least 90% by weight, preferably at least 94% by weight, EGCG and a maximum of 0.1% by weight caffeine. The invention relates, furthermore, in a further preferred embodiment, of course also to the use of isomaltulose in a formulation containing a polyphenol containing composition for taste masking. In a particularly preferred embodiment, the taste masking is taste masking of a polyphenol-containing composition. (00930521.1} -9 In a further preferred embodiment of the present invention, the invention relates to the use of a formulation of the present invention for increasing fat burning in mammals, in particular in humans. In a further preferred embodiment, the present invention relates to the use of an above-mentioned formulation for supporting fat metabolism in mammals, in particular in humans. In a further preferred embodiment, the present invention relates to the use of an above-mentioned formulation for reducing the fat mass in mammals, in particular in humans. In a further preferred embodiment of the present invention, the present invention relates to the use of an above-mentioned formulation for producing a medicament for increasing fat burning and/or for supporting fat metabolism and/or for reducing the fat mass in mammals, in particular in humans. The invention also relates, furthermore, to an instant powder containing 50 to 80% by weight isomaltulose, 0.1 to 10% by weight EGCG, 0.1 to 10% by weight caffeine, and also 0.005 to 1.0% by weight B vitamins. In the context of the present invention, mammals are taken to mean, in particular, humans, cats, dogs and horses. In the context of the present invention, B vitamins are taken to mean in particular vitamin B 1 , vitamin B 2 and nicotinamide. {00930521.1) - 10 In a preferred embodiment, EGCG is applied in the formulations and uses according to the invention in such a manner that the effective dose of EGCG is from 0.14 to 25 mg/kg of bodyweight/day, preferably from 2.0 to 9.0 mg/kg of bodyweight/day, particularly preferably from 4.0 to 9.0 mg/kg of bodyweight/day, and in particular from 4.0 to 4.5 mg/kg of bodyweight/day, In a preferred embodiment of the present invention, the polyphenol-containing composition is a plant extract, in particular an isolated and purified, in particular highly purified, plant extract, in particular a tea extract. In a further preferred embodiment, the extract is an extract of black tea, of Oolong tea, or of green tea, preferably an extract of leaves of green tea, that is to say Camellia sinensis. In a further preferred embodiment, the extract of the above-mentioned type contains additionally natural or nature identical odor and/or taste substances. According to the invention it is preferably provided that isomaltulose is used in order to mask the bitter taste of the polyphenol-containing composition present in a formulation of the present invention, that is to say to make it unrecognizable or not perceivable, or perceivable to a greatly reduced extent. In a preferred embodiment of the present invention, such a formulation is a composition which is intended or suitable for human or animal consumption, for {00930521.1) - 11 example a drink powder, an instant powder, a product for oral hygiene, a cosmetics product, a dry flavor formula, a foodstuff, food or article consumed for pleasure, or a feed. In a preferred embodiment, this formulation can be present in dry form, preferably in free-flowing form, in particular in agglomerated, pulverized and/or freeze-dried form. The invention also relates, in particular, to possibly coated formulations which are in the form of compactates, capsules or tablets as foods, articles consumed for pleasure, foodstuffs or medicaments, an instant powder, as drink powder, as drinks or as cosmetics and also products for oral hygiene. Of course, the formulation can also be used in order to produce drinks, that is to say to act as instant powder, in particular instant tea powder or as dry flavor formula. The effects observed according to the invention are then found in the drink produced by means of the formulation according to the invention, for example a tea drink, which is likewise subject matter of the present teaching. In a further preferred embodiment, in the formulation according to the invention food-compatible acids and/or salts can also be present. In a further preferred embodiment of the invention, intense sweeteners, for example saccharin, saccharin-Na, saccharin-K, saccharin-Ca, sodium cyclamate, calcium cyclamate, acesulfame-K, aspartame, dulcin, stevioside, neohesperedine dihydrochalcone or sucralose can {00930521.1} - 12 also be present in the formulation according to the invention. In a further preferred embodiment, antioxidants, stabilizers, minerals and/or trace elements can be present in the formulation. In a further preferred embodiment, vitamins can also be present in the formulation according to the invention, for example natural or synthetic vitamins, in particular vitamin A, vitamin B 1 , vitamin B 2 , vitamin B 3 , vitamin B 5 , vitamin B 6 , vitamin B 12 , vitamin B complex, nicotinamide, vitamin C, vitamin E, vitamin F and vitamin K. In a further preferred embodiment, the formulations according to the invention can contain flow enhancers, for example silica. In a further preferred embodiment, the formulations according to the invention can contain natural and/or synthetic dyes, for example dyes of plant origin, animal origin, inorganic pigments, products of enzymatic browning, products of non-enzymatic browning and carbohydrate heating products. As synthetic dyes, use can be made of, for example, azo compounds, triphenylmethane compounds, indigoid compounds, xanthene compounds or quinoline compounds. In a further preferred embodiment, the present invention relates to an above-mentioned formulation, wherein the fraction of polyphenol-containing composition in the formulation is 0.1 to 10% by weight, preferably 0.3 to 10% by weight, in particular 0.3 to 5% by weight, preferably 0.6 to (00930521.1} - 13 9% by weight, in particular 0.7 to 8% by weight, more preferably 0.9 to 7% by weight, in particular 1 to 5% by weight (in each case based on the dry matter of the formulation). In a further preferred embodiment, the present invention relates to an above-mentioned formulation, wherein the fraction of isomaltulose in the formulation is preferably 30 to 85% by weight, preferably 30 to 80% by weight, preferably 50 to 80% by weight, in particular 35 to 75% by weight, in particular 40 to 70% by weight, preferably 45 to 65% by weight, in particular 50 to 61% by weight (in each case based on the dry matter of the formulation). In a further preferred embodiment, the present invention relates to an above-mentioned formulation, wherein the fraction of food-compatible acids in the formulation is 5 to 10% by weight (based on the dry matter of the formulation). In a further preferred embodiment, the present invention relates to an above-mentioned formulation, wherein the fraction of intense sweeteners in the formulation is 0.1 to 1% by weight (based on the dry matter of the formulation). In a further preferred embodiment, the present invention relates to an above-mentioned formulation, wherein the fraction of taste substances in the formulation is 0.5 to 30% by weight (based on the dry matter of the formulation). (00930521.1) - 14 In a further preferred embodiment, the formulation according to the invention, apart from isomaltulose, does not contain any further sugars, in particular does not contain sucrose, fructose and/or glucose. Preferably, isomaltulose is the sole sugar present in the formulation, in particular the sole sweetening agent present in the formulation. In the context of the present invention, the term sweetening agent is taken to mean a substance which has sweetening power and is added, for example, to foods or drinks in order to give rise to a sweet taste. In the context of the present invention, the sweetening agents are sub divided into sugars, such as isomaltulose, sucrose, glucose or fructose, which give body and sweetening power, and also "sweeteners", that is to say substances which are not sugars, but nevertheless have sweetening power, which in turn are subdivided into "sugar replacers", that is to say sweetening agents which have body and physiological calorific value in addition to sweetening power (bulking sweeteners) and "intense sweeteners", that is to say substances which generally have a very high sweetening power, but do not have body and generally have no, or only very low, physiological calorific value. In a particularly preferred embodiment, the formulation according to the invention is protective to teeth, acariogenic and/or dietetic. {00930521.1) - 15 According to the invention, however, in a further embodiment it can be provided that the isomaltulose is used together with intense sweeteners and/or if appropriate also sugar replacers, for example isomalt, in the formulation. In a further preferred embodiment, the invention relates to the polyphenol-containing formulations according to the invention containing isomaltulose together with at least one, preferably strongly sweetening, carbohydrate, which preferably has an equivalent sweetening power of > 0.5, based on a 10% strength sucrose solution, e.g. sucrose, fructose, glucose, invert sugar and/or oligofructose. The invention also relates to polyphenol-containing formulations according to the invention containing isomaltulose and glucose-containing, fructose-containing and/or leucrose containing syrups, for example sucromalt. The invention also relates to polyphenol-containing formulations according to the invention containing isomaltulose and mixtures of sucrose, glucose and/or fructose with other carbohydrates. The strongly masking sensory properties of isomaltulose, in particular in combination with strongly sweetening carbohydrates, deliver in polyphenol-containing, in particular in Teavigo-containing drink formulas, a balanced and rounded sweetness profile with a full mouthfeel, compared with products which are sweetened classically. In particular, the preferred polyphenol-containing formulations according to the invention having a carbohydrate (00930521.1} - 16 fraction, in particular isomaltulose fraction, of 30 to 85%, preferably 45 to 65%, in drinks exhibit a pronounced beneficial total sensory impression. Further advantageous embodiments of the present invention are given by the subclaims. The invention will be described in more detail with reference to an exemplary embodiment. Example Formula 1 (Comparative formula) Components Instant powder rtd (g/200 ml) (g/kg) Maltodextrin 569.300 8.540 Citric acid, anhydrous 66.670 1.000 powder Trisodium citrate, 12.500 0.188 dihydrate powder TWINSWEET@ 3.330 0.050 Grapefruit taste 8.330 0.125 TEAVIGO@ 2.540 0.038 Caffeine 3.330 0.050 CustoMix BE-P 0.670 0.010 Grapefruit 250L powder 333.330 5.000 Total 1000.000 15.000 Formula 2 with sucrose (Comparative formula) Components Instant powder rtd (g/200 ml) (g/kg) Sucrose 607.800 6.078 Citric acid, anhydrous 80.000 0.800 powder Trisodium citrate, 14.400 0.144 {00930521.1) - 17 dihydrate powder TWINSWEET@ 3.000 0.030 Grapefruit taste 11.000 0.110 TEAVIGO@ 3.800 0.038 Caffeine 4.000 0.040 CustoMix BE-P 1.000 0.010 Grapefruit 250L powder 275.000 2.750 Total 1000.000 10.000 Formula 3 with isomaltulose Components Instant powder rtd (g/200 ml) (g/kg) Isomaltulose 607.800 6.078 Citric acid, anhydrous 80.000 0.800 powder Trisodium citrate, 14.400 0.144 dihydrate powder TWINSWEET@ 3.000 0.030 Grapefruit taste 11.000 0.110 TEAVIGO@ 3.800 0.038 Caffeine 4.000 0.040 CustoMix BE-P 1.000 0.010 Grapefruit 250L powder 275.000 2.750 Total 1000.000 10.000 Formula 4 with isomaltulose Components Instant powder rtd (g/250 ml) (g/kg) Isomaltulose 583.300 7.000 Citric acid, anhydrous 83.300 1.000 powder Trisodium citrate, 15.000 0.180 dihydrate powder (00930521.1} - 18 TWINSWEET@ 4.200 0.050 Grapefruit taste 11.500 0.138 TEAVIGO@ 3.200 0.038 Caffeine 4.200 0.050 CustoMix BE-P 0.800 0.010 Grapefruit 250L powder 294.500 3.534 Total 1000.000 12.000 Formula 5 with isomaltulose and sucrose Components Instant powder rtd (g/200 ml) (g/kg) Isomaltulose 407.800 4.078 Sucrose 200.000 2.000 Citric acid, anhydrous 80.000 0.800 powder Trisodium citrate, 14.400 0.144 dihydrate powder TWINSWEET@ 3.000 0.030 Grapefruit taste 11.000 0.110 TEAVIGO@ 3.800 0.038 Caffeine 4.000 0.040 CustoMix BE-P 1.000 0.010 Grapefruit 250L powder 275.000 2.750 Total 1000.000 10.000 Formula 6 with isomaltulose and fructose Components Instant powder rtd (g/200 ml) (g/kg) Isomaltulose 457.800 4.578 Fructose 150.000 1.500 Citric acid, anhydrous 80.000 0.800 powder Trisodium citrate, 14.400 0.144 {00930521.1) - 19 dihydrate powder TWINSWEET@ 3.000 0.030 Grapefruit taste 11.000 0.110 TEAVIGO@ 3.800 0.038 Caffeine 4.000 0.040 CustoMix BE-P 1.000 0.010 Grapefruit 250L powder 275.000 2.750 Total 1000.000 10.000 Formula 7 with isomaltulose and dry glucose Components Instant powder rtd (g/200 ml) (g/kg) Isomaltulose 207.800 2.078 Dry glucose (from Agrana) 400.000 4.000 Citric acid, anhydrous 80.000 0.800 powder Trisodium citrate, 14.400 0.144 dihydrate powder TWINSWEET@ 3.000 0.030 Grapefruit taste 11.000 0.110 TEAVIGO@ 3.800 0.038 Caffeine 4.000 0.040 CustoMix BE-P 1.000 0.010 Grapefruit 250L powder 275.000 2.750 Total 1000.000 10.000 Formula 8 with isomaltulose/invert sugar syrup compound* Components Instant powder rtd (g/200 ml) (g/kg) Isomaltulose fraction in 487.800 4.878 the compound Invert sugar fraction in 120.000 1.200 the compound Citric acid, anhydrous 80.000 0.800 (00930521.1) - 20 powder Trisodium citrate, 14.400 0.144 dihydrate powder TWINSWEET@ 3.000 0.030 Grapefruit taste 11.000 0.110 TEAVIGO@ 3.800 0.038 Caffeine 4.000 0.040 CustoMix BE-P 1.000 0.010 Grapefruit 250L powder 275.000 2.750 Total 1000.000 10.000 * The compound was produced by agglomeration, wherein finely ground isomaltulose was used and the slightly diluted invert sugar solution (roughly the same parts of sucrose, glucose and fructose) having a dry matter content of approximately 60% was sprayed on as binder component. For the above-mentioned formulas, the column "instant powder" gives the concentration of the formula component specified in each case in g/kg in the overall formulation. The column "rtd" (ready to drink) gives the specified concentration of the formula component in grams per 200 ml in a drink produced using the formulation. For Comparative Formula 1, per 200 ml of drink, 15 g of the instant powder were used, whereas in formula 2, 3, 5 to 8, use was made of 10 g of the instant powder according to the invention per 200 ml of drink, and in Formula 4, 12 g per 250 ml of drink. TEAVIGO@ is a highly purified extract of leaves of the green tea Camellia sinensis and has at least 90% by weight, preferably at least 94% by weight, EGCG and a maximum (00930521.1) - 21 of 0.1% by weight of caffeine. For production of the drink, the formulation was dissolved in water with stirring so as to be ready to drink. The drink was presented to a trained panel of 15 testers for tasting. The testers, in the context of a profile analysis with scale, had to evaluate the bitterness (on drinking and aftertaste), the sweetness impression, the mouthfeel, the flavor impression and the overall impression of the drinks produced from the formulas. The attributes were defined as follows on a scale from 0 to 5: Bitterness (on drinking): 0 = unpleasantly bitter; 5 = bitter note scarcely perceptible Bitterness (aftertaste): 0 = unpleasantly bitter; 5 = bitter note scarcely perceptible Sweetness impression: 0 = unbalanced; 5 = balanced, round Mouthfeel: 0 = unpleasant, 5 = full bodied, pleasant Aroma impression: 0 = short, flat; 5 = long-lasting, balanced Overall impression: 0 = unbalanced, qualitatively bad; 5 = balanced, round, qualitatively good The testers, in a statistically meaningful manner, established for the comparative formula, not only during the tasting, but also immediately thereafter, a significantly more bitter taste than for the formulas according to the invention. Further advantages were also demonstrated in the {00930521.1) - 22 other attributes tested. In particular in the case of sweetness and overall impression, the products according to the invention containing the isomaltulose-carbohydrate mixtures exhibit very good sensory property profiles. The results of the profile analysis are summarized numerically in the table. These results are surprising, since the formulas vary with respect to sweetening power. Sweetening power is apparently not the parameter responsible for hiding the bitter note, that is to say concealing the same amount of bitter substances, in particular of polyphenol-containing extract, that is TEAVIGO@. The data show that isomaltulose, together with a polyphenol-containing composition, effects a particularly beneficial sensory profile. If isomaltulose is used in combination with at least one strongly sweetening carbohydrate, for example fructose, glucose, sucrose and/or invert sugar, this gives a further improved, beneficial, sensory profile. {00930521.1} (U) U-) (3) L) -iC 0 E4 0 U) '-4 0 (V(N h C E- 4 ODC0O o 0) E- 'to 'IQ (1 U).) H4 0j -4 U 0 V) W -' E o- NaD '-4 0 rz r4 0 U)) 0 EH LN.- W( Q0) U)) 44 0 (Y)N( ()C C, 0 -4 (U 00)L V)U 4- $4( 0 0 V) rl 0) U) -4 0C',0 Q) (o E H Qr U) 4-) 0)() () ) ri U (Iw U) 44 V - U) U) H4 U) U) U) 0 0 u 0)V 4- 4J 0 U) 4) U) H w U) 4-) 4H -) 4-4 (1) U) I4- (-1 U) H 4 r- r- (a) E~ 0) 5-4 > ~ Q - E- n 0 Q *- (f) *H r-4 * 0 *)
Claims (37)
1. Formulation containing a polyphenol-containing composition and isomaltulose.
2. Formulation according to Claim 1, wherein the polyphenol-containing composition has a fraction of at least 90% by weight, preferably at least 94% by weight, of EGCG, based on the weight of the dry matter of the polyphenol containing composition.
3. Formulation according to Claim 1 or 2, wherein the polyphenol-containing composition has a fraction of at most 2.5% by weight of caffeine, preferably at most 0.1% by weight, in each case based on the weight of the dry matter of the polyphenol-containing composition.
4. Formulation according to one of the preceding claims, wherein the polyphenol-containing composition has a fraction of at most 2.5% by weight of gallocatechin gallate (GCG), based on the weight of the dry matter of the polyphenol containing composition.
5. Formulation according to one of the preceding claims, wherein the polyphenol-containing composition has a fraction of at most 5.0% by weight of epicatechin gallate (ECG), preferably at most 3.0% by weight, in each case based on the weight of the dry matter of the polyphenol-containing composition. {00930521.1} - 25
6. Formulation according to one of the preceding claims, wherein the polyphenol-containing composition has a fraction of at most 0.1% by weight of gallic acid, based on the weight of the dry matter of the polyphenol-containing composition.
7. Formulation according to one of the preceding claims, wherein the polyphenol-containing composition, apart from EGCG, has a fraction of at most 5.0% by weight of other polyphenols and catechins such as gallocatechin gallate (GCG), catechin gallate (CG), epicatechin gallate (ECG), epigallocatechin (EGC), gallocatechin (GC) and epicatechin (EC), based on the weight of the dry matter of the polyphenol-containing composition.
8. Formulation according to one of the preceding claims, wherein the formulation has 30 to 85% by weight isomaltulose (based on the weight of the dry matter of the formulation).
9. Formulation according to one of the preceding claims, wherein the formulation, in addition to the isomaltulose, has at least one strongly sweetening carbohydrate.
10. Formulation according to Claim 9, wherein the fraction of isomaltulose and the strongly sweetening carbohydrate of the formulation is 30 to 85% by weight (based on the weight of the dry matter of the formulation).
11. Use of a formulation according to one or more of Claims 1 to 10 for increasing fat burning in mammals, in particular in humans. (00930521.1} - 26
12. Use of a formulation according to one or more of Claims 1 to 10 for supporting fat metabolism in mammals, in particular in humans.
13. Use of a formulation according to one or more of Claims 1 to 10 for reducing the fat mass in mammals, in particular in humans.
14. Use of isomaltulose in a formulation containing a polyphenol-containing composition, in particular a formulation according to one of Claims 1 to 10 for taste masking.
15. Use according to Claim 14, wherein the taste masking is taste masking of a polyphenol-containing composition.
16. Use according to one of Claims 11 to 15, wherein the polyphenol-containing composition is a plant extract.
17. Use according to one of Claims 11 to 16, wherein the plant extract is an extract of black tea, an extract of Oolong tea or an extract of green tea.
18. Use according to one of Claims 11 to 17, wherein the extract contains additional natural or nature-identical odor and/or taste substances.
19. Use according to one of Claims 11 to 18, wherein the polyphenol-containing composition is epigallocatechin gallate (EGCG).
20. Use according to one of Claims 11 to 19, wherein the EGCG is present in the polyphenol-containing composition in a fraction of at least 90% by weight, preferably at least 94% (00930521.1) - 27 by weight (in each case based on the dry matter of the polyphenol-containing composition).
21. Use according to one of Claims 11 to 20, wherein the fraction of polyphenol-containing composition in the formulation is 0.1 to 10% by weight (based on the dry matter of the formulation).
22. Use according to one of Claims 11 to 21, wherein the fraction of polyphenol-containing composition in the formulation is 0.3 to 5% by weight (based on the dry matter of the formulation).
23. Use according to one of Claims 11 to 22, wherein the fraction of isomaltulose in the formulation is 30 to 85% by weight (based on the dry matter of the formulation).
24. Use according to one of Claims 11 to 23, wherein the fraction of isomaltulose in the formulation is 40 to 70% by weight (based on the dry matter of the formulation).
25. Use according to one of Claims 11 to 24, wherein the fraction of isomaltulose in the formulation is 50 to 61% by weight (based on the dry matter of the formulation).
26. Use according to one of Claims 11 to 25, wherein the formulation is an instant powder, a dry flavor formula, a drink powder, a food, an article consumed for pleasure or a medicament.
27. Use according to one of Claims 11 to 26, wherein the formulation contains food-compatible acids, food-compatible {00930521.1) - 28 salts, intense sweeteners, taste substances, flavor or odor substances, a further sweetening agent and/or caffeine.
28. Use according to one of Claims 11 to 27, wherein the fraction of food-compatible acids in the formulation is 5 to 10% by weight (based on the dry matter of the formulation).
29. Use according to one of Claims 11 to 28, wherein the fraction of intense sweeteners in the formulation is 0.1 to 1% by weight (based on the dry matter of the formulation).
30. Use according to one of Claims 11 to 29, wherein the fraction of taste substances in the formulation is 0.5 to 30% by weight (based on the dry matter of the formulation).
31. Use according to one of Claims 11 to 30, wherein the formulation is in dry form.
32. Use according to one of Claims 11 to 31, wherein the formulation is in freeze-dried, agglomerated or pulverized form.
33. Use according to one of Claims 11 to 32, wherein the formulation contains flow enhancers, in particular silica.
34. Use according to one of Claims 11 to 33, wherein the formulation contains natural and/or synthetic dyes.
35. Use according to one of Claims 11 to 34, wherein the formulation contains natural or synthetic vitamins.
36. Use according to one of Claims 11 to 35, wherein the formulation contains minerals and trace elements. {00930521.1) - 29
37. Instant powder containing 50 to 80% by weight isomaltulose, 0.1 to 10% by weight EGCG, 0.1 to 10% by weight caffeine, and also 0.005 to 1.0% by weight B vitamins. {00930521.1) PCT/EP/2006/011219 September 17, 2007 SC-ta Applicant: Sudzucker Our Reference: 200469 Aktiengesellschaft... Patent Claims 1. Formulation containing 0.1 to 10% by weight polyphenol-containing composition (based on the dry matter of the formulation) having a fraction of at least 90% by weight of EGCG (based on the dry matter of the polyphenol-containing composition) and 30 to 80% by weight isomaltulose (based on the dry matter of the formulation). 2. Formulation according to Claim 1, wherein the polyphenol-containing composition has a fraction of at least 94% by weight of EGCG, based on the weight of the dry matter of the polyphenol-containing composition. 3. Formulation according to Claim 1 or 2, wherein the polyphenol-containing composition has a fraction of at most 2.5% by weight of caffeine, preferably at most 0.1% by weight, in each case based on the weight of the dry matter of the polyphenol-containing composition. 4. Formulation according to one of the preceding claims, wherein the polyphenol-containing composition has a fraction of at most 2.5% by weight of gallocatechin gallate (GCG), based on the weight of the dry matter of the polyphenol containing composition. (00930524.1) 5. Formulation according to one of the preceding claims, wherein the polyphenol-containing composition has a fraction of at most 5.0% by weight of epicatechin gallate (ECG), preferably at most 3.0% by weight, in each case based on the weight of the dry matter of the polyphenol-containing composition. 6. Formulation according to one of the preceding claims, wherein the polyphenol-containing composition has a fraction of at most 0.1% by weight of gallic acid, based on the weight of the dry matter of the polyphenol-containing composition. 7. Formulation according to one of the preceding claims, wherein the polyphenol-containing composition, apart from EGCG, has a fraction of at most 5.0% by weight of other polyphenols and catechins such as gallocatechin gallate (GCG), catechin gallate (CG), epicatechin gallate (ECG), epigallocatechin (EGC), gallocatechin (GC) and epicatechin (EC), based on the weight of the dry matter of the polyphenol-containing composition. 8. Formulation according to one of the preceding claims, wherein the formulation, in addition to the isomaltulose, has at least one strongly sweetening carbohydrate. 9. Formulation according to Claim 8, wherein the fraction of isomaltulose and the strongly sweetening carbohydrate of the formulation is 30 to 85% by weight (based on the weight of the dry matter of the formulation). {00930524.1) 10. Use of a formulation according to one or more of Claims 1 to 9 for increasing fat burning in mammals, in particular in humans. 11. Use of a formulation according to one or more of Claims 1 to 9 for supporting fat metabolism in mammals, in particular in humans. 12. Use of a formulation according to one or more of Claims 1 to 9 for reducing the fat mass in mammals, in particular in humans. 13. Use of isomaltulose in a formulation containing a polyphenol-containing composition, in particular a formulation according to one of Claims 1 to 9 for taste masking. 14. Use according to Claim 13, wherein the taste masking is taste masking of a polyphenol-containing composition. 15. Use according to one of Claims 10 to 14, wherein the polyphenol-containing composition is a plant extract. 16. Use according to one of Claims 10 to 15, wherein the plant extract is an extract of black tea, an extract of Oolong tea or an extract of green tea. 17. Use according to one of Claims 10 to 16, wherein the extract contains additional natural or nature-identical odor and/or taste substances. 18. Use according to one of Claims 10 to 17, wherein the polyphenol-containing composition is epigallocatechin gallate (EGCG). {00930524.1) 19. Use according to one of Claims 10 to 18, wherein the EGCG is present in the polyphenol-containing composition in a fraction of at least 94% by weight (in each case based on the dry matter of the polyphenol-containing composition). 20. Use according to one of Claims 10 to 19, wherein the fraction of polyphenol-containing composition in the formulation is 0.3 to 5% by weight (based on the dry matter of the formulation). 21. Use according to one of Claims 10 to 20, wherein the fraction of isomaltulose in the formulation is 40 to 70% by weight (based on the dry matter of the formulation). 22. Use according to one of Claims 10 to 21, wherein the fraction of isomaltulose in the formulation is 50 to 61% by weight (based on the dry matter of the formulation). 23. Use according to one of Claims 10 to 22, wherein the formulation is an instant powder, a dry flavor formula, a drink powder, a food, an article consumed for pleasure or a medicament. 24. Use according to one of Claims 10 to 23, wherein the formulation contains food-compatible acids, food-compatible salts, intense sweeteners, taste substances, flavor or odor substances, a further sweetening agent and/or caffeine. 25. Use according to one of Claims 10 to 24, wherein the fraction of food-compatible acids in the formulation is 5 to 10% by weight (based on the dry matter of the formulation). (00930524.1) 26. Use according to one of Claims 10 to 25, wherein the fraction of intense sweeteners in the formulation is 0.1 to 1% by weight (based on the dry matter of the formulation). 27. Use according to one of Claims 10 to 26, wherein the fraction of taste substances in the formulation is 0.5 to 30% by weight (based on the dry matter of the formulation). 28. Use according to one of Claims 10 to 27, wherein the formulation is in dry form. 29. Use according to one of Claims 10 to 28, wherein the formulation is in freeze-dried, agglomerated or pulverized form. 30. Use according to one of Claims 10 to 29, wherein the formulation contains flow enhancers, in particular silica. 31. Use according to one of Claims 10 to 30, wherein the formulation contains natural and/or synthetic dyes. 32. Use according to one of Claims 10 to 31, wherein the formulation contains natural or synthetic vitamins. 33. Use according to one of Claims 10 to 32, wherein the formulation contains minerals and trace elements. 34. Instant powder containing 50 to 80% by weight isomaltulose, 0.1 to 10% by weight EGCG, 0.1 to 10% by weight caffeine, and also 0.005 to 1.0% by weight B vitamins. {00930524.1)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005056652A DE102005056652A1 (en) | 2005-11-25 | 2005-11-25 | Preparation, useful for increasing fat combustion, supporting fat metabolism, reducing fat content in mammals, preferably humans, comprises a polyphenol composition and isomaltulose |
DE102005056652.9 | 2005-11-25 | ||
PCT/EP2006/011219 WO2007059953A1 (en) | 2005-11-25 | 2006-11-23 | Formulation comprising a polyphenol-containing composition and isomaltulose |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2006316813A1 true AU2006316813A1 (en) | 2007-05-31 |
AU2006316813B2 AU2006316813B2 (en) | 2011-10-20 |
Family
ID=37806144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2006316813A Active AU2006316813B2 (en) | 2005-11-25 | 2006-11-23 | Formulation comprising a polyphenol-containing composition and isomaltulose |
Country Status (12)
Country | Link |
---|---|
US (3) | US20080261897A1 (en) |
EP (1) | EP1973423B1 (en) |
JP (1) | JP5078905B2 (en) |
KR (1) | KR101376125B1 (en) |
CN (1) | CN101415341B (en) |
AU (1) | AU2006316813B2 (en) |
BR (1) | BRPI0618919B1 (en) |
DE (1) | DE102005056652A1 (en) |
ES (1) | ES2625255T3 (en) |
PL (1) | PL1973423T3 (en) |
RU (1) | RU2391863C2 (en) |
WO (1) | WO2007059953A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005034043B4 (en) * | 2005-07-18 | 2019-12-12 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Mixture containing L-carnitine and trehalulose and product containing the mixture |
US9101160B2 (en) | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
US8017168B2 (en) | 2006-11-02 | 2011-09-13 | The Coca-Cola Company | High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
MX2009008269A (en) * | 2007-02-23 | 2009-08-12 | Basf Se | Method for modulating the taste of material compisitions containing at least one high intensity sweetener (his). |
GB2450076B (en) * | 2007-05-17 | 2012-09-26 | Sis Science In Sport Ltd | Nutritional composition |
DE102007026975A1 (en) * | 2007-06-01 | 2008-12-04 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Antioxidant for food |
JP5801327B2 (en) * | 2010-03-05 | 2015-10-28 | マース インコーポレーテッドMars Incorporated | Delicious beverages and compositions containing cocoa extracts |
EP2641477B2 (en) * | 2012-03-19 | 2022-06-08 | Symrise AG | Compositions of matter |
DE102012017884A1 (en) * | 2012-08-03 | 2014-02-20 | Krüger Gmbh & Co. Kg | Composition for the delayed absorption |
JP6100498B2 (en) * | 2012-10-15 | 2017-03-22 | 三井製糖株式会社 | Method for producing matcha-containing food and food containing matcha |
US11330828B2 (en) | 2016-10-07 | 2022-05-17 | Hayashibara Co., Ltd. | Powdery plant extract for beverages and process for producing the same |
IT201700096298A1 (en) | 2017-08-25 | 2019-02-25 | Penta Holding | Method for the production of a polyphenolic composition from barley malt |
KR20190047873A (en) * | 2017-10-30 | 2019-05-09 | (주)아모레퍼시픽 | Composition for preventing and improving lipid metabolism-related disorder containing tea extract which includes elevated amounts of specific ingredient |
EP3488849A1 (en) * | 2017-11-23 | 2019-05-29 | Assistance Publique, Hopitaux De Paris | Epigallocathechin gallate solution |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE4770T1 (en) * | 1979-11-07 | 1983-10-15 | Tate & Lyle Public Limited Company | MANUFACTURE OF PRODUCTS FOR HUMAN OR ANIMAL CONSUMPTION USING A SUCrose SUBSTITUTE. |
JPH0763294B2 (en) * | 1990-03-30 | 1995-07-12 | サントリー株式会社 | Anti-cariogenic food |
JP3763075B2 (en) * | 1998-04-24 | 2006-04-05 | サンスター株式会社 | Food composition, oral composition and pharmaceutical composition for prevention or treatment of periodontal disease |
JP2000069945A (en) * | 1998-09-01 | 2000-03-07 | Sunstar Inc | Beverage blended with extract of grape rind and seed, and production thereof |
EP1767097A3 (en) * | 1999-08-16 | 2007-04-04 | DSMIP Assets B.V. | Green tea extracts |
CN1352902A (en) * | 2000-11-10 | 2002-06-12 | 杨术华 | Multi-taste instant tea and its preparing process |
KR100374142B1 (en) * | 2000-12-14 | 2003-02-26 | 동서식품주식회사 | Alternative sweetener |
JPWO2003017788A1 (en) * | 2001-08-30 | 2004-12-09 | 新三井製糖株式会社 | Beverages containing flower or herb flavor or flower or herb extract |
JP3920654B2 (en) * | 2002-02-08 | 2007-05-30 | 三井製糖株式会社 | Modified soymilk or soymilk drink and method for improving the flavor of prepared soymilk or soymilk drink |
DE10226203B4 (en) * | 2002-06-13 | 2008-04-03 | Südzucker AG Mannheim/Ochsenfurt | Condensed Palatinose, process for its preparation and its use |
WO2004000045A2 (en) * | 2002-06-21 | 2003-12-31 | Canacure Corporation | Liquid compositions comprising non-digestible oligosaccharides and green tea catechins, method and uses thereof |
CA2493934A1 (en) * | 2002-07-19 | 2004-01-29 | Suedzucker Aktiengesellschaft Mannheim/Ochsenfurt | Isomaltulose-containing instant beverage powder |
DE10234191B4 (en) * | 2002-07-26 | 2006-10-19 | Südzucker AG Mannheim/Ochsenfurt | Improved marking fluids |
JP4048166B2 (en) * | 2002-11-18 | 2008-02-13 | 三井製糖株式会社 | Glucose level rise inhibitor, body fat accumulation inhibitor, and edible material |
JP2004219141A (en) * | 2003-01-10 | 2004-08-05 | Ricoh Co Ltd | Semiconductor testing device |
AU2004262887A1 (en) * | 2003-07-23 | 2005-02-17 | Cerestar Holding B.V. | Isomaltulose or trehalose containing comestibles for sustained carbohydrate energy release and increased fat oxidation |
JP2005245351A (en) * | 2004-03-05 | 2005-09-15 | Yakult Honsha Co Ltd | Acidic beverage |
DE102004052800B4 (en) * | 2004-10-30 | 2017-02-23 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Improved carrier formulations |
-
2005
- 2005-11-25 DE DE102005056652A patent/DE102005056652A1/en not_active Ceased
-
2006
- 2006-11-23 KR KR1020087015192A patent/KR101376125B1/en active IP Right Grant
- 2006-11-23 WO PCT/EP2006/011219 patent/WO2007059953A1/en active Application Filing
- 2006-11-23 EP EP06829109.5A patent/EP1973423B1/en active Active
- 2006-11-23 CN CN2006800516822A patent/CN101415341B/en active Active
- 2006-11-23 PL PL06829109T patent/PL1973423T3/en unknown
- 2006-11-23 AU AU2006316813A patent/AU2006316813B2/en active Active
- 2006-11-23 ES ES06829109.5T patent/ES2625255T3/en active Active
- 2006-11-23 US US12/094,253 patent/US20080261897A1/en not_active Abandoned
- 2006-11-23 BR BRPI0618919-9A patent/BRPI0618919B1/en active IP Right Grant
- 2006-11-23 RU RU2008125847/15A patent/RU2391863C2/en active
- 2006-11-23 JP JP2008541637A patent/JP5078905B2/en active Active
-
2013
- 2013-04-04 US US13/856,598 patent/US20130224349A1/en not_active Abandoned
-
2015
- 2015-09-03 US US14/844,874 patent/US20150374019A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE102005056652A1 (en) | 2007-05-31 |
KR20080074189A (en) | 2008-08-12 |
RU2008125847A (en) | 2009-12-27 |
WO2007059953A1 (en) | 2007-05-31 |
US20080261897A1 (en) | 2008-10-23 |
RU2391863C2 (en) | 2010-06-20 |
KR101376125B1 (en) | 2014-03-27 |
PL1973423T3 (en) | 2017-08-31 |
EP1973423A1 (en) | 2008-10-01 |
WO2007059953A8 (en) | 2007-08-02 |
ES2625255T3 (en) | 2017-07-19 |
BRPI0618919A2 (en) | 2011-09-13 |
US20150374019A1 (en) | 2015-12-31 |
EP1973423B1 (en) | 2017-03-15 |
CN101415341B (en) | 2012-09-05 |
CN101415341A (en) | 2009-04-22 |
BRPI0618919B1 (en) | 2020-03-10 |
AU2006316813B2 (en) | 2011-10-20 |
JP2009517352A (en) | 2009-04-30 |
US20130224349A1 (en) | 2013-08-29 |
JP5078905B2 (en) | 2012-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2006316813B2 (en) | Formulation comprising a polyphenol-containing composition and isomaltulose | |
US9044038B2 (en) | Method of improving sweetness qualities of stevia extract | |
CN111031805B (en) | Sweetness and taste improvement of dihydrochalcones on steviol glycosides and mogroside sweeteners | |
EP1959762B1 (en) | High-potency sweetener composition for treatment and/or prevention of autoimmune disorders, compositions and beverages sweetened therewith | |
AU2012355414B2 (en) | Methods for using rebaudioside C as a flavor enhancer | |
CN108289489B (en) | Steviol glycoside compositions for oral ingestion or use | |
EP2543263A1 (en) | High-potency sweetener composition with antioxidant and compositions sweetened therewith | |
JP6353364B2 (en) | Composition | |
JP2009517038A (en) | High-intensity sweetener composition for weight management and composition sweetened thereby | |
JPWO2003007734A1 (en) | Taste improving composition and its application | |
CN109219355B (en) | Sweetness and taste improvement of steviol glycoside or mogroside sweeteners | |
KR20200021525A (en) | Intraoral Sweetener Compositions and Methods | |
JP2001258502A (en) | Sweetener composition, method for imparting sweetness and its use | |
JP2004033226A (en) | Sweetener composition, method for imparting sweetness and application thereof | |
JP7307608B2 (en) | Tea leaf feeling enhancer and tea-containing composition containing the same | |
CA3061592C (en) | Sweetener composition and method for improving taste of stevia extract | |
KR20240046918A (en) | Compositions and methods comprising caffeine and/or derivatives thereof and polyphenols | |
RU2588540C2 (en) | Composition for intensive sweetener with antioxidant and compositions sweetened therewith | |
AU2013201603A1 (en) | High-potency sweetener composition with antioxidant and compositions sweetened therewith |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |